The Precision Medicine Company
Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies
AlphaBiomics contributes to Knowledge Transfer Network Microbiome Strategic Roadmap.
Read more here.
The Precision Medicine Company
Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies
Winner of the 2018 European Innovation Quickfire Challenge (read more)